Search Site

Trends banner

Luberef net profit falls 7% in Q1

A fall in by-products sales leads to profit dip.

SABIC net loss $322 million

The company's net profit was $66m in Q1 2024

PureHealth posts $137m Q1 net profit

The Group's revenue increased 8 percent YoY.

Borouge Q1 net profit $281 million

The total dividend paid to shareholders in 2024 $1.3bn.

Emirates expects first 777X delivery in H2 2026

Boeing had pushed back the first delivery to 2026 from 2025.

UAE to lift Covid curbs on activities, events slowly

The update comes in line with the UAE's strategy to protect public health and safety and ensure returning to normalcy.
  • This was revealed during the media briefing on the pandemic by Dr. Saif Al Dhaheri and Dr. Farida Al Hosani, official spokespersons for NCEMA and health sector respectively
  • Dr Al Hosani highlighted the importance of community responsibility and the pivotal role of community members in supporting the efforts to achieve sustainable recovery

The United Arab Emirates on Wednesday decided to gradually lifting the restrictions on activities, events capacities following the decline in the Covid infections. 

This was revealed during the media briefing on the coronavirus pandemic by Dr. Saif Al Dhaheri, Official Spokesperson for the National Crisis and Emergency Management Authority (NCEMA). 

Dr. Farida Al Hosani, Official Spokesperson of the UAE Health Sector, highlighted the importance of community responsibility and the pivotal role of community members in  supporting the efforts to achieve sustainable recovery.

She continued that all sectors are fully cooperating with the health sector and are constantly monitoring the pandemic both locally and internationally, to ensure an immediate response.   “The specialist teams are providing the necessary support to ensure the timely treatment of infections, monitor those exposed to infected cases, and provide the necessary medical equipment, treatments and vaccines,”Dr  Al Hosani said. “The health sector is also using the best systems to ensure rapid intervention, aided by qualified medical personnel.” 

Dr. Al Hosani pointed out the Pfizer-BioNTech vaccine will be provided to children aged between 5 and 11 in accredited health centres.

“Scientific studies conducted by relevant international advisory commissions in charge of ensuring the safety of COVID-19 vaccines, including the Pfizer-BioNTech vaccine for children, confirmed its clear that it benefits all age groups, as it reduces infections, hospitalisations, ICU admissions and deaths,” she further said.